why choose us

First received: May 02, 2023

Clinical Trial: Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Metastatic Colorectal Cancer

Study Type: INTERVENTIONAL


Official Title: Phase II Study of Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer

Brief Summary: This study is being done to see if combining liposomal irinotecan with TAS102 and bevacizumab confers clinical benefit for patients with treatment refractory metastatic colorectal cancer.

Read more